Cargando…

Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process

Prostate cancer has a predilection to metastasise to the bone marrow stroma (BMS) by an as yet uncharacterised mechanism. We have defined a series of coculture models of invasion, which simulate the blood/BMS boundary and allow the elucidation of the signalling and mechanics of trans-endothelial mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, C A, Brown, M, Bagley, S, Sharrard, M, Clarke, N W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362089/
https://www.ncbi.nlm.nih.gov/pubmed/15668715
http://dx.doi.org/10.1038/sj.bjc.6602325
_version_ 1782153375775719424
author Hart, C A
Brown, M
Bagley, S
Sharrard, M
Clarke, N W
author_facet Hart, C A
Brown, M
Bagley, S
Sharrard, M
Clarke, N W
author_sort Hart, C A
collection PubMed
description Prostate cancer has a predilection to metastasise to the bone marrow stroma (BMS) by an as yet uncharacterised mechanism. We have defined a series of coculture models of invasion, which simulate the blood/BMS boundary and allow the elucidation of the signalling and mechanics of trans-endothelial migration within the complex bone marrow environment. Confocal microscopy shows that prostate epithelial cells bind specifically to bone marrow endothelial-to-endothelial cell junctions and initiate endothelial cell retraction. Trans-endothelial migration proceeds via an epithelial cell pseudopodial process, with complete epithelial migration occurring after 232±43 min. Stromal-derived factor-1 (SDF-1)/CXCR4 signalling induced PC-3 to invade across a basement membrane although the level of invasion was 3.5-fold less than invasion towards BMS (P=0.0007) or bone marrow endothelial cells (P=0.004). Maximal SDF-1 signalling of invasion was completely inhibited by 10 μM of the SDF-1 inhibitor T140. However, 10 μM T140 only reduced invasion towards BMS and bone marrow endothelial cells by 59% (P=0.001) and 29% (P=0.011), respectively. This study highlights the need to examine the potential roles of signalling molecules and/or inhibitors, not just in single-cell models but in coculture models that mimic the complex environment of the bone marrow.
format Text
id pubmed-2362089
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23620892009-09-10 Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process Hart, C A Brown, M Bagley, S Sharrard, M Clarke, N W Br J Cancer Translational Therapeutics Prostate cancer has a predilection to metastasise to the bone marrow stroma (BMS) by an as yet uncharacterised mechanism. We have defined a series of coculture models of invasion, which simulate the blood/BMS boundary and allow the elucidation of the signalling and mechanics of trans-endothelial migration within the complex bone marrow environment. Confocal microscopy shows that prostate epithelial cells bind specifically to bone marrow endothelial-to-endothelial cell junctions and initiate endothelial cell retraction. Trans-endothelial migration proceeds via an epithelial cell pseudopodial process, with complete epithelial migration occurring after 232±43 min. Stromal-derived factor-1 (SDF-1)/CXCR4 signalling induced PC-3 to invade across a basement membrane although the level of invasion was 3.5-fold less than invasion towards BMS (P=0.0007) or bone marrow endothelial cells (P=0.004). Maximal SDF-1 signalling of invasion was completely inhibited by 10 μM of the SDF-1 inhibitor T140. However, 10 μM T140 only reduced invasion towards BMS and bone marrow endothelial cells by 59% (P=0.001) and 29% (P=0.011), respectively. This study highlights the need to examine the potential roles of signalling molecules and/or inhibitors, not just in single-cell models but in coculture models that mimic the complex environment of the bone marrow. Nature Publishing Group 2005-02-14 2005-01-25 /pmc/articles/PMC2362089/ /pubmed/15668715 http://dx.doi.org/10.1038/sj.bjc.6602325 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Translational Therapeutics
Hart, C A
Brown, M
Bagley, S
Sharrard, M
Clarke, N W
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
title Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
title_full Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
title_fullStr Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
title_full_unstemmed Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
title_short Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
title_sort invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362089/
https://www.ncbi.nlm.nih.gov/pubmed/15668715
http://dx.doi.org/10.1038/sj.bjc.6602325
work_keys_str_mv AT hartca invasivecharacteristicsofhumanprostaticepithelialcellsunderstandingthemetastaticprocess
AT brownm invasivecharacteristicsofhumanprostaticepithelialcellsunderstandingthemetastaticprocess
AT bagleys invasivecharacteristicsofhumanprostaticepithelialcellsunderstandingthemetastaticprocess
AT sharrardm invasivecharacteristicsofhumanprostaticepithelialcellsunderstandingthemetastaticprocess
AT clarkenw invasivecharacteristicsofhumanprostaticepithelialcellsunderstandingthemetastaticprocess